glipizide has been researched along with Angiogenesis, Pathologic in 3 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed at investigating the effect of glipizide combined with ANP on breast cancer." | 8.12 | Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling. ( Cao, J; Li, J; Liu, X; Mao, G; Qi, C; Wang, L; Zhang, Q; Zheng, L; Zheng, S; Zhou, Q, 2022) |
| "This study aimed at investigating the effect of glipizide combined with ANP on breast cancer." | 4.12 | Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling. ( Cao, J; Li, J; Liu, X; Mao, G; Qi, C; Wang, L; Zhang, Q; Zheng, L; Zheng, S; Zhou, Q, 2022) |
| "We further revealed that the anticancer capability of glipizide is not attributed to its antiproliferative effects, which are not significant against various human cancer cell lines." | 1.40 | Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis. ( Cao, L; Ding, Y; He, X; Lan, T; Lee, KK; Li, B; Li, J; Li, W; Qi, C; Song, X; Wang, H; Wang, J; Wang, L; Yang, X; Yang, Y; Ye, Y; Zhang, Q; Zhou, J; Zhou, Q, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Mao, G | 1 |
| Zheng, S | 1 |
| Li, J | 2 |
| Liu, X | 1 |
| Zhou, Q | 2 |
| Cao, J | 1 |
| Zhang, Q | 2 |
| Zheng, L | 1 |
| Wang, L | 2 |
| Qi, C | 2 |
| Whittam, AJ | 1 |
| Maan, ZN | 1 |
| Duscher, D | 1 |
| Barrera, JA | 1 |
| Hu, MS | 1 |
| Fischer, LH | 1 |
| Khong, S | 1 |
| Kwon, SH | 1 |
| Wong, VW | 1 |
| Walmsley, GG | 1 |
| Giacco, F | 1 |
| Januszyk, M | 1 |
| Brownlee, M | 1 |
| Longaker, MT | 1 |
| Gurtner, GC | 1 |
| Li, B | 1 |
| Yang, Y | 1 |
| Cao, L | 1 |
| Ye, Y | 1 |
| Ding, Y | 1 |
| Wang, H | 1 |
| Wang, J | 1 |
| He, X | 1 |
| Lan, T | 1 |
| Lee, KK | 1 |
| Li, W | 1 |
| Song, X | 1 |
| Zhou, J | 1 |
| Yang, X | 1 |
3 other studies available for glipizide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling.
Topics: Angiogenesis Inhibitors; Animals; Atrial Natriuretic Factor; Breast Neoplasms; Cell Movement; Cell P | 2022 |
Small molecule inhibition of dipeptidyl peptidase-4 enhances bone marrow progenitor cell function and angiogenesis in diabetic wounds.
Topics: Animals; Chemokine CXCL12; Diabetes Mellitus, Experimental; Dipeptidyl Peptidase 4; Dipeptidyl-Pepti | 2019 |
Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chick Embr | 2014 |